But it is a temporary condition that will go away over some time
Lipo 360 is ideal for patients who are near their ideal weight but struggle with persistent fat deposits that do not respond to diet and exercise
As a consequence, levels of adherence are lower than for people with diabetes, as demonstrated by another study that applied the same metric of adherence to people using GLP-1s to treat obesity: 40.1% for Ozempic (semaglutide, Novo Nordisk), 31.5% for weekly injectable Wegovy and just 15% for daily injectable Saxenda (liraglutide, Novo Nordisk).10 This suggests that greater expectation management is required to maintain users faith in the value and purpose of what they are doing
Understanding GLP Drugs: What They Are and Why People Take Them We have probably all seen the recent press on GLP drugs, or glucagon-like peptide-1 receptor agonists
These innovations not only expand therapeutic options but also address unmet needs in obesity and metabolic care, attracting wider clinical adoption
These cases typically involve hospitalization, surgery, or lasting impairment